A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

referredUnited States· United States Congress· EN

Introduced

10 June 2008

Last action

—

Status

Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5455-5456)

Summary

Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians unless it holds a public comment period on the issue and can document evidence of adverse events and other safety issues to justify such policy.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

Introduced in Senate (text)
Introduced in Senate · EN · 10 June 2008
View Download Open at official source
Introduced in Senate (PDF)
Introduced in Senate · EN · 10 June 2008
View Download Open at official source
Introduced in Senate
summary · EN · 10 June 2008
Open at official source

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/110th-congress/senate-concurrent-resolution/88
Open data entity: https://api.congress.gov/v3/bill/110/sconres/88